SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-058861
Filing Date
2023-12-15
Accepted
2023-12-15 18:07:07
Documents
1
Period of Report
2023-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4009
  Complete submission text file 0001209191-23-058861.txt   5604
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 455 MISSION BAY BOULEVARD SOUTH C/O NEKTAR THERAPEUTICS SAN FRANCISCO CA 94158
Business Address
Zalevsky Jonathan (Reporting) CIK: 0001789857 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24006 | Film No.: 231491705